EUVIMEDEUVIMED entdecken
Crossref

Boosting Cancer Immunotherapy via Reversing PD-L1–Mediated Immunosuppression with a Molecularly Imprinted Lysosomal Nanodegrader

Haifeng Lu, Peixin Guan, Shuxin Xu, Yanjie Han, Zhen Liu iD

ACS Nano · 2024

DOI: 10.1021/acsnano.4c07416 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, 2024. Verfasst von Haifeng Lu und 4 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Analytical Chemistry for Life Science, School of Chemistry and Chemical Engineering, Nanjing University, 163 Xianlin Avenue, …. Hauptthemen laut MEDLINE: B7-H1 Antigen, Lysosomes, Immunotherapy, Molecular Imprinting. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Key Programme, Anhui Provincial Department of Education, Nanjing University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

B7-H1 AntigenLysosomesImmunotherapyMolecular ImprintingAnimalsHumansMiceCell Line, TumorNanoparticlesFemaleNeoplasmsCell ProliferationMice, Inbred BALB C

Stichwörter der Autor:innen

PD-L1immune checkpointlysosomal degradationmolecularly imprinted polymertumor immunotherapy

Substanzen

B7-H1 AntigenCD274 protein, human

Autor:innen und Institutionen

  • State Key Laboratory of Analytical Chemistry for Life Science, School of Chemistry and Chemical Engineering, Nanjing University, 163 Xianlin Avenue, Nanjing 210023, China.

ORCID-Profile: Zhen Liu

Förderung

  • Key Programme
  • Anhui Provincial Department of Education
  • Nanjing University
  • Excellent Young Scientists Fund

Zitieren

APA

Lu, H., Guan, P., Xu, S., Han, Y., & Liu, Z. (2024). Boosting Cancer Immunotherapy via Reversing PD-L1–Mediated Immunosuppression with a Molecularly Imprinted Lysosomal Nanodegrader. ACS Nano. https://doi.org/10.1021/acsnano.4c07416

Vancouver

Lu H, Guan P, Xu S, Han Y, Liu Z. Boosting Cancer Immunotherapy via Reversing PD-L1–Mediated Immunosuppression with a Molecularly Imprinted Lysosomal Nanodegrader. ACS Nano. 2024. doi:10.1021/acsnano.4c07416

BibTeX
@article{Lu2024,
  author = {Lu, Haifeng and Guan, Peixin and Xu, Shuxin and Han, Yanjie and Liu, Zhen},
  title = {Boosting Cancer Immunotherapy via Reversing PD-L1–Mediated Immunosuppression with a Molecularly Imprinted Lysosomal Nanodegrader},
  journal = {ACS Nano},
  year = {2024},
  doi = {10.1021/acsnano.4c07416}
}
Kostenlos starten →